Trial Profile

A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics in Healthy Chinese Adults

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 09 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Deutenzalutamide (Primary)
Indications Breast cancer; Prostate cancer
Focus Pharmacokinetics
Sponsors Hinova pharmaceuticals; Sichuan Haisco Pharmaceutical

Most Recent Events

01 Feb 2022 Results published in the Prostate
30 Oct 2020 Status changed from recruiting to completed.
19 Aug 2019 Planned End Date changed from 30 Jun 2019 to 30 Oct 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com